India Lowers Prices Of 63 More Drugs, Some By Two-Thirds
This article was originally published in PharmAsia News
Executive Summary
India's pricing agency has lowered the costs of 63 more drugs, including the cancer drug paclitaxel by 66%. Most of the drugs added to the list were considered life-savers to fight cancer, infection and viruses.